NEPHROGEN

nephrogen-logo

Nephrogen is a biotech company in New York City developing curative gene therapy drugs for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

#SimilarOrganizations #People #Financial #Website #More

NEPHROGEN

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical Therapeutics

Founded:
2015-08-22

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.nephrogenbiotech.com

Total Employee:
1+

Status:
Active

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Cloudflare JS CDN JS AJAX Libraries API CloudFront OpenResty Varnish


Similar Organizations

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

lucy-therapeutics-logo

Lucy Therapeutics

Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria.

neurovation-labs-logo

Neurovation Labs

Neurovation Labs is a biotech company focused CNS disorders, starting first with Post-traumatic Stress Disorder (PTSD).

ocugenix-logo

Ocugenix

Ocugenix is a therapeutics company that develops treatments for angio-fibrotic diseases of the eye.

Current Employees Featured

demetri-maxim_image

Demetri Maxim
Demetri Maxim Founder & CEO @ Nephrogen
Founder & CEO
2015-08-24

Founder


demetri-maxim_image

Demetri Maxim

Investors List

stanfordstartx-fund_image

StartX (Stanford-StartX Fund)

StartX (Stanford-StartX Fund) investment in Seed Round - Nephrogen

Official Site Inspections

http://www.nephrogenbiotech.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K

  • Host name: 198.202.211.1
  • IP address: 198.202.211.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Nephrogen"

Nephrogen

Nephrogen is a preclinical biotech company developing curative gene therapies for kidney diseases. Our initial indication is autosomal dominant polycystic kidney disease (ADPKD), which affects 600,000 Americans and has no cure or โ€ฆSee details»

Nephrogen - Crunchbase Company Profile & Funding

Nephrogen is a biotech company in New York City developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease โ€ฆSee details»

Nephrogen - LinkedIn

Curative gene therapies for kidney diseases | Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD),...See details»

Nephrogen Company Profile 2024: Valuation, Funding โ€ฆ

Operator of a drug discovery platform intended to treat kidney diseases.See details»

Nephrogen Company Profile | Management and Employees List

Nephrogen is a therapeutics company developing transformative medicines for kidney disease. Our initial focus is on gene therapy for autosomal dominant polycystic kidney disease โ€ฆSee details»

Nephrogen - Work in biotech

Nephrogen is a biotech company developing gene therapies for life-threatening kidney diseases. They aim to deliver curative treatments through a combination of CRISPR/Cas9 gene editing โ€ฆSee details»

Nephrogen - Y Combinator Startup | YC Batch S20

Domain: nephrogenbiotech.com; Email: [email protected]; Industries: Medical, Therapeutics, Biotechnology, Health Care; Tags: gene-therapy, crispr, biotechSee details»

Nephrogen - Overview, News & Similar companies | ZoomInfo.com

Nephrogen contact info: Phone number: (978) 799-8358 Website: www.nephrogenbiotech.com What does Nephrogen do? Nephrogen is a therapeutics company developing transformative โ€ฆSee details»

Nephrogen Inc. Company Profile | New York, NY - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Nephrogen Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»

Nephrogen - Products, Competitors, Financials, Employees, โ€ฆ

Nephrogen develops curative gene therapies for kidney diseases within the biotechnology sector. Its offerings include a platform that combines genome editing with nucleic acid delivery โ€ฆSee details»

Nephrogen: Curative gene therapies for kidney โ€ฆ

Curative gene therapies for kidney diseases. Founded in 2020 by Demetri Maxim, Nephrogen has 1 employees based in New York, NY, USA. Nephrogen is hiring for 1 roles in science.See details»

Nephrogen Management Team | Org Chart - RocketReach

Nephrogen employs 4 employees. The Nephrogen management team includes Demetri Maxim (Founder and CEO) . Sorry, this org chart isn't available at this time. Check back later! Looking โ€ฆSee details»

Nephrogen: Contact Details and Business Profile - RocketReach

Nephrogen is a Biotechnology Research, Business Services General, and Biotechnology company_reader located in New York, New York with $5 million in revenue and 4 employees. โ€ฆSee details»

Jobs at Nephrogen - Y Combinator

Why you should join Nephrogen. Nephrogen. Founded: 2020See details»

Nephrogen Company Insights, Tech Stack, and Competitors | 6sense

Nephrogenbiotech.com. Type. Private Nephrogen Technology Stack. Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, โ€ฆSee details»

Nephrogen on LinkedIn: Nephrogen was delighted to present at โ€ฆ

Last Thursday, NewYorkBIO hosted the second Mini Pitch Day of the year in collaboration with JLABS @ NYC. Each of the ten presenting companies offered a new approach to therapeutic โ€ฆSee details»

โ€ŽColumbia University BioWorks: BioWorks 16: CRISPR ... - Apple โ€ฆ

In which Nephrogen founder Demetri Maxim discusses his work developing curative gene therapy for kidney diseases. He shares the companyโ€™s origin as a diagnostic device startup and shift to โ€ฆSee details»

BioWorks 16: CRISPR for Kidney - Apple Podcasts

Mar 24, 2024ย ยท In which Nephrogen founder Demetri Maxim discusses his work developing curative gene therapy for kidney diseases. He shares the companyโ€™s origin as a diagnostic โ€ฆSee details»

Nephrogen on LinkedIn: Nephrogen

Organoids, highly advanced and accurate disease models, are revolutionizing drug screening and reshaping pharmaceutical strategies. ?? With their ability to mimic human organs and tissues,...See details»

Nephrogen - Email & Phone of top management contacts

[email protected] ****609*** View Number: CSR: CSR Head and Director: Nephrogen: [email protected] ****778*** View Number: Nephrogen technology โ€ฆSee details»

linkstock.net © 2022. All rights reserved